Benign Prostatic Hyperplasia (BPH) is a common condition in men over the age of 50, where the prostate gland enlarges and causes urinary symptoms. It is a major concern in Urology and Nephrology, as it can lead to complications such as urinary retention, bladder stones, and even kidney failure. Treatment options for BPH include lifestyle changes, medications, and minimally invasive procedures.
The BPH market is composed of a variety of products and services, including medications, medical devices, and surgical procedures. Medications used to treat BPH include alpha-blockers, 5-alpha reductase inhibitors, and anticholinergics. Medical devices used to treat BPH include transurethral resection of the prostate (TURP) and transurethral microwave thermotherapy (TUMT). Surgical procedures used to treat BPH include open prostatectomy and laparoscopic prostatectomy.
Some companies in the BPH market include Allergan, Boston Scientific, Medtronic, and Urovant Sciences. Show Less Read more
